71 related articles for article (PubMed ID: 23578501)
21. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
22. Observer agreement and accuracy in the evaluation of bone scans in newly diagnosed prostate cancer.
Zacho HD; Manresa JA; Mortensen JC; Bertelsen H; Petersen LJ
Nucl Med Commun; 2015 May; 36(5):445-51. PubMed ID: 25646705
[TBL] [Abstract][Full Text] [Related]
23. A reappraisal of serial isotope bone scans in prostate cancer.
O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF
Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
[TBL] [Abstract][Full Text] [Related]
24. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
Oesterling JE; Martin SK; Bergstralh EJ; Lowe FC
JAMA; 1993 Jan; 269(1):57-60. PubMed ID: 7677962
[TBL] [Abstract][Full Text] [Related]
25. [Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].
Fukushi K; Koie T; Yamamoto H; Okamoto A; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
Hinyokika Kiyo; 2013 Apr; 59(4):247-50. PubMed ID: 23635462
[TBL] [Abstract][Full Text] [Related]
26. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
27. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
28. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
[TBL] [Abstract][Full Text] [Related]
29. A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer.
Reza M; Kaboteh R; Sadik M; Bjartell A; Wollmer P; Trägårdh E
BMC Med Imaging; 2018 May; 18(1):8. PubMed ID: 29728144
[TBL] [Abstract][Full Text] [Related]
30. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
31. The "super" bone scan.
Higginbotham EA
J Natl Med Assoc; 1980 Mar; 72(3):291-4. PubMed ID: 7392072
[No Abstract] [Full Text] [Related]
32. Application of bone scans for prostate cancer staging: Which guideline shows better result?
Chong A; Hwang I; Ha JM; Yu SH; Hwang EC; Yu HS; Kim SO; Jung SI; Kang TW; Kwon DD; Park K
Can Urol Assoc J; 2014 Jul; 8(7-8):E515-9. PubMed ID: 25210554
[TBL] [Abstract][Full Text] [Related]
33. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
34. Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer.
Zacho HD; Barsi T; Mortensen JC; Mogensen MK; Bertelsen H; Josephsen N; Petersen LJ
Clin Nucl Med; 2014 Jan; 39(1):26-31. PubMed ID: 24217537
[TBL] [Abstract][Full Text] [Related]
35. [When should we perform a bone scintigraphy in patients with new diagnosis of asymptomatic prostate cancer in order to detect bone metastasis?].
Márquez-López J; Gómez-Gómez E; Anaya-Henares F; Robles-Casilda R; Requena-Tapia MJ
Arch Esp Urol; 2015 Mar; 68(2):135-41. PubMed ID: 25774820
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
37. [The building and validation of a model to predict the bone metastases of patients with newly diagnosed prostate cancer].
Zhou JQ; Zhu Y; Yao XD; Zhang SL; Dai B; Zhang HL; Ye DW
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):999-1002. PubMed ID: 23302484
[TBL] [Abstract][Full Text] [Related]
38. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
39. Improved detection of prostate cancer using classification and regression tree analysis.
Garzotto M; Beer TM; Hudson RG; Peters L; Hsieh YC; Barrera E; Klein T; Mori M
J Clin Oncol; 2005 Jul; 23(19):4322-9. PubMed ID: 15781880
[TBL] [Abstract][Full Text] [Related]
40. Prediction of tumor absorbed dose by Tc-99m-MDP scintigraphy prior to treatment with Sr-89.
Manetou A; Limourls GS
Anticancer Res; 1997; 17(3B):1845-7. PubMed ID: 9179243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]